Cardiac Shunt Delivery with Stagnation-Assisted Contrast Visualization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing medical procedures face challenges in accurately visualizing and securing cardiac shunts due to rapid blood flow, which dilutes contrast solutions, and there is a need for effective methods to reduce elevated pressures in heart chambers like the left atrium and pulmonary artery.

Innovation Solution

A delivery system is provided that includes a stagnation device to impede blood flow, allowing concentrated contrast visualization and secure implant placement, using expandable shunts with anchoring arms that are deployed between the coronary sinus and left atrium, facilitated by a catheter system.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If contrast solution is injected to visualize the cardiac shunt, then the shunt can be seen, but the rapid blood flow dilutes the contrast solution and reduces visualization quality

Engineering Contradiction:
Improvevisualization qualityVSAvoidcontrAST concentration
Core Design Contradiction:
Measurement precisionVSQuantity of substance

Solution Approach 1:

The stagnation device is deployed before contrast injection to create a stagnation zone that prevents blood flow from washing away the contrast solution. This preliminary action counteracts the diluting effect of blood flow, allowing the contrast to remain concentrated and providing clear visualization of the cardiac shunt.

Inventive Principle:
Principle #9Preliminary anti-action

Solution Approach 2:

The stagnation device acts as an intermediary element between the contrast solution and the rapidly flowing blood. It creates a protected zone where the contrast can accumulate and maintain its concentration, effectively mediating between the need for visualization and the harmful effect of blood flow dilution.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If the delivery system includes additional components like stagnation device, then visualization and positioning improve, but the device complexity increases

Engineering Contradiction:
Improveimplant positioning accuracyVSAvoiddelivery system complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The stagnation device is integrated with the delivery catheter system, allowing both the shunt and stagnation device to be delivered through the same access pathway. This merging of functions reduces the need for separate devices and procedures, thereby limiting the increase in overall system complexity while still improving positioning accuracy.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The delivery system is designed to perform multiple functions: delivering the shunt, deploying the stagnation device, and enabling visualization. By making the delivery system multi-functional, the patent avoids needing separate specialized devices for each function, thus limiting the increase in device complexity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables precise implant positioning and visualization by maintaining contrast concentration, reducing blood flow interference, and effectively managing pressures in heart chambers.

Implementation Method 1

a stagnation device to impede blood flow, allowing concentrated contrast visualization

Methodology Applied
Scientific EffectFluid flow impedance:

Data Source

PatentEP4358870B1Cardiac shunt delivery system with a stagnation device
Publication Date: 2026.04.01 EDWARDS LIFESCIENCES CORP
  • EP4358870B1 patent drawingFigure 1~2
  • EP4358870B1 patent drawingFigure 3
  • EP4358870B1 patent drawingFigure 4~5

AI summary

A method comprises delivering a medical implant and a delivery device to a tissue wall within a heart of a patient. The delivery device can be attached to the medical implant. The method further involves maneuvering the delivery device to place at least a portion of the medical implant at a desired position with respect to the tissue wall and delivering an expandable stagnation device proximate to the medical implant. The expandable stagnation device is configured to at least partially inhibit blood flow. The method further involves injecting a contrast solution between at least a portion of the medical implant and at least a portion of the expandable stagnation device, collapsing the expandable stagnation device, and detaching the delivery device from the medical implant.